AMETEK (NYSE:AME) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Key Points

• Royal Bank of Canada raised its price target on AMETEK to $260 (from $259) and keeps an "outperform" rating, implying roughly a 12.9% upside from the prior close.
• AMETEK beat Q1 expectations with $1.97 EPS and $1.93B revenue, reported double‑digit organic revenue growth, and raised FY‑2026 guidance to $7.94–$8.14 EPS (Q2 guide $1.96–2.00).
• Press reports say AMETEK is exploring a multibillion‑dollar acquisition, a development that may be driving short‑term selling pressure and investor uncertainty.

AMETEK (NYSE:AME - Get Free Report) had its price target boosted by Royal Bank Of Canada from $259.00 to $260.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an "outperform" rating on the technology company's stock. Royal Bank Of Canada's price target would indicate a potential upside of 12.94% from the stock's previous close.

AME has been the topic of several other research reports. Barclays upped their target price on shares of AMETEK from $210.00 to $220.00 and gave the stock an "equal weight" rating in a report on Wednesday, February 4th. TD Cowen reiterated a "buy" rating on shares of AMETEK in a research report on Tuesday, February 3rd. Melius Research set a $235.00 price target on shares of AMETEK in a research report on Monday, January 5th. Weiss Ratings reiterated a "buy (b)" rating on shares of AMETEK in a research report on Wednesday, January 21st. Finally, Morgan Stanley upped their price target on shares of AMETEK from $215.00 to $235.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, AMETEK presently has an average rating of "Moderate Buy" and an average target price of $248.58.

AMETEK Price Performance

Shares of AME traded down $5.30 during trading hours on Friday, hitting $230.20. The stock had a trading volume of 613,560 shares, compared to its average volume of 1,330,071. The company's fifty day moving average is $225.56 and its two-hundred day moving average is $212.81. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.06 and a quick ratio of 0.67. AMETEK has a 52 week low of $167.75 and a 52 week high of $242.05. The stock has a market capitalization of $52.73 billion, a price-to-earnings ratio of 35.91, a P/E/G ratio of 3.27 and a beta of 1.04.

AMETEK (NYSE:AME - Get Free Report) last posted its earnings results on Thursday, April 30th. The technology company reported $1.97 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.07. AMETEK had a net margin of 20.00% and a return on equity of 16.55%. The business had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the prior year, the firm earned $1.75 EPS. The firm's quarterly revenue was up 11.3% compared to the same quarter last year. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. On average, analysts anticipate that AMETEK will post 8.04 EPS for the current year.

Insider Transactions at AMETEK

In other AMETEK news, Director Thomas A. Amato sold 530 shares of the company's stock in a transaction dated Tuesday, March 24th. The shares were sold at an average price of $216.78, for a total transaction of $114,893.40. Following the transaction, the director directly owned 4,480 shares in the company, valued at approximately $971,174.40. This represents a 10.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.54% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Candriam S.C.A. lifted its position in AMETEK by 23.3% during the 1st quarter. Candriam S.C.A. now owns 18,422 shares of the technology company's stock valued at $3,949,000 after purchasing an additional 3,487 shares during the period. Kestra Advisory Services LLC lifted its position in AMETEK by 1.2% during the 1st quarter. Kestra Advisory Services LLC now owns 21,370 shares of the technology company's stock valued at $4,581,000 after purchasing an additional 246 shares during the period. Resona Asset Management Co. Ltd. lifted its position in AMETEK by 0.9% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 69,357 shares of the technology company's stock valued at $14,791,000 after purchasing an additional 597 shares during the period. Sageworth Trust Co acquired a new position in AMETEK during the 1st quarter valued at about $274,000. Finally, Montag A & Associates Inc. raised its position in shares of AMETEK by 0.7% in the 1st quarter. Montag A & Associates Inc. now owns 51,361 shares of the technology company's stock valued at $11,010,000 after acquiring an additional 343 shares during the period. 87.43% of the stock is currently owned by institutional investors and hedge funds.

Key AMETEK News

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q1 results: AMETEK reported EPS of $1.97 and revenue of $1.93B, beating consensus and showing double‑digit organic revenue growth year‑over‑year — a key near‑term fundamental positive. AMETEK NYSE: AME Beats Q1 CY2026 Sales Expectations
• Positive Sentiment: Company raised its organic sales outlook to mid‑single digits and described the quarter as record‑setting, and stated it has increased its internal full‑year outlook versus prior guidance (management view of stronger business momentum). AMETEK Announces Record First Quarter 2026 Results and Raises Full Year Guidance
• Neutral Sentiment: Definitive agreement to acquire First Aviation Services (adds defense/aviation MRO capabilities and proprietary components) — strategic tuck‑in but not large disclosed terms; investors will watch integration and cost. AMETEK Announces Agreement to Acquire First Aviation Services
• Neutral Sentiment: Investor materials and full earnings call transcript/slides are available for detail on segment performance, margins and end‑market commentary — useful for assessing sustainability of the beat. AMETEK, Inc. (AME) Q1 2026 Earnings Call Transcript
• Negative Sentiment: FY‑2026 EPS guidance was set at $7.94–$8.14 and Q2 EPS at $1.96–2.00. While the range is an increase versus AMETEK’s prior internal view, the midpoint is roughly in line with or slightly below some analysts’ consensus — a reason for investor caution despite the beat. Ametek forecasts 2026 EPS of $7.94 to $8.14 while raising organic sales outlook to mid-single digits
• Negative Sentiment: Press and WSJ reports that AMETEK is exploring a multibillion‑dollar acquisition (exclusive talks) — potential large M&A can create short‑term uncertainty (financing, multiples, integration risk) and likely contributed to today’s selling pressure. Ametek near purchase of CD&R-owned industrial company - WSJ

AMETEK Company Profile

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.